natgillin/translations-raw huggingface dataset:
There is a linear relationship between the dose administered and plasma concentration observed in the therapeutic dose range in dogs.
Porazdelitev Med vnesenim odmerkom in koncentracijo v plazmi je pri terapevtskem razponu odmerkov pri psih in mačkah linearno razmerje.
White to off-white viscous oral suspension.
Bele do umazano bele barve, viskozna peroralna suspenzija
meat and offal: 15 days; milk: 5 days.
meso in organi: 15 dni; mleko: 5 dni
Treatment should be discontinued after 10 days at the latest if no clinical improvement is apparent.
Če se klinično stanje ne izboljša, je treba zdravljenje najpozneje po 10 dneh prekiniti.
In very rare cases loss of appetite, lethargy, abdominal pain and colitis have been reported.
V zelo redkih primerih so poročali o izgubi apetita, zaspanosti, bolečini v trebuhu in kolitisu.
Chewable tablets.
Žvečljiva tableta
THE WORDS “FOR ANIMAL TREATMENT ONLY”
BESEDILO ''SAMO ZA ŽIVALI'' Samo za živali.
Pack size: 20 and 100 sachets.
Velikosti pakiranj: 20 in 100 vrečicami.
Meloxicam is completely absorbed following oral administration and maximal plasma concentrations are obtained after approximately 4.5 hours.
Meloksikam se po peroralnem dajanju povsem absorbira in doseže največje koncentracije v plazmi po približno 4,5 ure.
EXP {month/year} Once opened use within 6 months.
Odprto zdravilo uporabite v 6 mesecih.
In case of overdose, adverse reactions, as listed in section "Adverse reactions", are expected to be more severe and more frequent.
Pri prevelikem odmerjanju lahko pričakujemo resnejše in pogostejše neželene učinkih kot so opisane v poglavju Neželeni učinki.
There is a linear relationship between the dose administered and plasma concentration observed in the therapeutic dose range.
Pri terapevtskem razponu odmerkov je med vnesenim odmerkom in koncentracijo v plazmi linearno razmerje.
Do not use in animals less than 6 weeks of age nor in cats of less than 2 kg.
Ne uporabite pri žpsih, mlajših od 6 tednov, in mačkah, žlažjih od 2 kg.
6.6 Special precautions for the disposal of unused veterinary medicinal products or waste materials derived from the use of such products
6.6 Posebni varnostni ukrepi za odstranjevanje neporabljenega zdravila ali odpadnih snovi, ki nastanejo pri uporabi teh zdravil
In-feed use.
Dajanje v krmno mešanico.
If you notice any side effects, even those not already listed in this package leaflet or you think that the medicine has not worked, please inform your veterinary surgeon.
Če opazite kakršne koli stranske učinke, tudi tiste, ki niso navedeni v tem navodilu za uporabo ali mislite,
A slight transient swelling at the injection site following subcutaneous administration was observed in less than 10 % of the cattle treated in clinical studies.
NEŽELENI UČINKI V kliničnih raziskavah so zasledili samo blago in prehodno oteklino na mestu podkožne injekcije, in sicer pri manj kot 10 % goveda.
Meloxicam is eliminated with a half-life of 26 hours and 17.5 hours after subcutaneous injection in young cattle and lactating cows, respectively.
Izločanje Razpolovna doba izločanja meloksikama je po podkožni injekciji pri mladem govedu in kravah v obdobju laktacije 26 oziroma 17,5 ure.
Approximately 75 % of the administered dose is eliminated via faeces and the remainder via urine.
Približno 75 % vnesenega odmerka se izloči z blatom, preostanek pa z urinom.
Oral suspension to be administered at a dosage of 0.6 mg/kg body weight, once daily, up to 14 days.
Peroralna suspenzija, ki jo dajemo v odmerkih po 0,6 mg/kg telesne mase, enkrat na dan, do 14 dni.
After initial treatment with Inflacam 5 mg/ml solution for injection for cats, continue treatment 24 hours later with Inflacam 0.5 mg/ml oral suspension for cats at a dosage of 0.05 mg meloxicam/kg body weight (0.1 ml /kg).
Po začetnem zdravljenju z zdravilom Inflacam 5 mg/ml raztopina za injiciranje za mačke nadaljujte zdravljenje 24 ur pozneje z zdravilom Inflacam 0,5 mg/ml peroralna suspenzija za mačke v odmerku 0,05
20 tablets 100 tablets
100 tablet
Chronic musculo-skeletal disorders:
Kronična mišično-skeletna obolenja:
B. CONDITIONS OR RESTRICTIONS REGARDING SUPPLY AND USE
B. POGOJI TER OMEJITVE GLEDE OSKRBE ALI UPORABE Na veterinarski recept.
Keep the vial in the outer carton.
Vialo shranjujete v zunanji ovojnini.
Pigs: Can be used during pregnancy and lactation.
Prašiči: Lahko se uporablja v obdobju brejosti in laktacije.
Once broached use by …
Načeto zdravilo uporabite do…
The suspension should be given using the measuring syringe provided in the package.
Suspenzijo je treba dajati s priloženo merilno brizgo.
Cardboard box
PODATKI NA ZUNANJI OVOJNINI Kartonska škatla
Marketing authorisation holder
IMETNIK DOVOLJENJA ZA PROMET
EXP {month/year} Once opened use within 3 months.
Odprto zdravilo uporabite v 3 mesecih.
Povidone
predstavitve
After two intramuscular doses of 0.4 mg meloxicam/kg, a Cmax value of 1.9 μg/ml was reached after 1 hour in pigs.
Po dveh intramuskularnih odmerkih meloksikama po 0,4 mg/kg je znašala Cmax pri prašičih po 1 uri 1,9 µg/ml.
Solution for injection.
injekcija.
In very rare cases elevated liver enzymes have been reported.
Zelo redko so poročali o zvišani ravni jetrnih encimov.
Do not use in cats less than 6 weeks of age.
Ne uporabite pri mačkah, mlajših od 6 tednov.
One chewable tablet contains:
NAVEDBA UČINKOVIN(E) Ena žvečljiva tableta vsebuje:
Label for 100 ml and 200 ml bottles
Nalepka za 100 ml in 200 ml plastenki
Musculo-skeletal disorders:
Mišično-skeletna obolenja:
In pigs, bile and urine contain only traces of the parent compound.
Pri prašičih vsebujeta žolč in urin samo sledi matične spojine.
Reduction of post-operative pain and inflammation following orthopaedic and soft tissue surgery.
Lajšanje pooperativne bolečine in zmanjšanje vnetja po ortopedskih operacijah in operacijah mehkega tkiva.
MANUFACTURER'S BATCH NUMBER Lot {number}
IZDELOVALČEVA ŠTEVILKA SERIJE Lot
Avoid use in very severely dehydrated, hypovolaemic or hypotensive animals which require parenteral rehydration, as there may be a potential risk of renal toxicity.
Zaradi možne nevarnosti toksičnih učinkov na ledvice se dajanju zdravila izogibamo pri zelo dehidriranih, hipovolemičnih ali hipotenzivnih živalih, ki potrebujejo parenteralno rehidracijo.
For the relief of post-operative pain following dehorning in calves.
Za lajšanje pooperativn bolečine po odstranitvi rogov teletom.
Pre-treatment with anti-inflammatory substances may result in additional or increased adverse effects and accordingly a treatment-free period with such veterinary medicinal products should be observed for at least 24 hours before commencement of treatment.
Predzdravljenje z zdravili s protivnetnim delovanjem lahko povzroči dodatne neželene učinke ali jih okrepi, zato teh zdravil za uporabo v veterinarski medicini ne smemo dajati najmanj 24 ur pred začetkom zdravljenja.
The treatment-free period, however, should take into account the pharmacokinetic properties of the veterinary products used previously.
Poleg tega je treba pri določanju obdobja brez zdravil upoštevati farmakokinetične lastnosti veterinarskih zdravil, ki smo jih dajali predhodno.
DATE OF FIRST AUTHORISATION/RENEWAL OF THE AUTHORISATION
DATUM PRIDOBITVE/PODALJŠANJA DOVOLJENJA ZA PROMET Datum pridobitve dovoljenja za promet:
Do not use in dogs less than 6 weeks of age.
Ne uporabite pri psih, mlajših od 6 tednov.
Meat and offal: 3 days.
Meso in organi: 3 dni.
These side effects are in most cases transient and disappear following termination of the treatment but in very rare cases may be serious or fatal.
Našteti neželeni učinki so večinoma prehodni in po prekinitvi zdravljenja minejo, vendar so lahko v zelo redkih primerih tudi resni ali smrtno nevarni.
For use in non-infectious locomotor disorders to reduce the symptoms of lameness and inflammation.
Za ublažitev ohromelosti in vnetja pri neinfekcijskih lokomotornih motnjah.
Use during pregnancy and lactation: See section “Contraindications”.
Uporaba v obdobju brejosti ali laktacije Glejte poglavje Kontraindikacije
Post-operative pain and inflammation following surgical procedures: In case additional pain relief is required, multimodal pain therapy should be considered.
V primeru potrebe po dodatnem lajašanju bolečine je treba razmisliti o multimodalnem zdravljenju bolečine.
In very rare cases, haemorrhagic diarrhoea, haematemesis, gastrointestinal ulceration and elevated liver enzymes have been reported.
V zelo redkih primerih so poročali o hemoragični diareji, bruhanju krvi (hematemeza) , gastro-intestinalnih ulkusih in povišani vrednosti jetrnih encimov.
In cattle, meloxicam is also a major excretion product in milk and bile whereas urine contains only traces of the parent compound.
Pri govedu je tudi pomembna sestavina pri izločanju zdravila z mlekom in žolčem, medtem ko vsebuje urin samo sledi matične spojine.
In cats, meloxicam is eliminated with a half-life of 24 hours.
Pri mačkah je razpolovna doba izločanja meloksikama 24 ur.
Carton for 15 ml, 42 ml, 100 ml or 200 ml bottle
PODATKI NA ZUNANJI OVOJNINI Škatla za 15 ml, 42 ml, 100 ml ali 200 ml plastenko
Solution for injection
injekcija
To be administered either mixed with food or directly into the mouth at a dosage of 0.6 mg/kg body weight, once daily, up to 14 days.
Zdravilo dajemo pomešano s hrano ali v gobec v odmerkih po 0,6 mg/kg telesne mase, enkrat na dan, do
E-mail: info@virbac.gr, www.virbac.gr
: + 30 210 8140900 E-mail: , www.virbac.gr
Post-operative pain: single intravenous or subcutaneous injection.
Pooperativna bolečina: enkratna intravenska ali podkožna injekcija Mačke: Pooperativna bolečina: enkratna podkožna injekcija
Following single intramuscular doses of 0.4 mg meloxicam/kg, a Cmax value of 1.1 to 1.5 μg/ml was reached within 1 hour in pigs.
Po enkratnem intramuskularnem odmerku meloksikama po 0,4 mg/kg je znašala Cmax pri prašičih po 1 uri 1,1-1,5 µg/ml.
After a single subcutaneous dose of 0.5 mg meloxicam/kg, Cmax values of 2.1 μg/ml and 2.7 μg/ml were reached after 7.7 hours and 4 hours in young cattle and lactating cows, respectively.
Po enkratnem podkožnem odmerku meloksikama po 0,5 mg/kg je znašala Cmax pri mladem govedu in kravah v obdobju laktacije 2,1 µg/ml in 2,7 µg/ml po 7,7 ure in 4 urah.
Inflacam 1 mg chewable tablets for dogs Inflacam 2.5 mg chewable tablets for dogs
Inflacam 1 mg žvečljive tablete za pse Inflacam 2,5 mg žvečljive tablete za pse
Shelf life after first opening of the container: 3 months.
Rok uporabnosti po prvem odpiranju vsebnika: 3 mesece.
Isolated cases of adverse reactions typically associated with non-steroidal anti-inflammatory drugs (NSAIDs) were observed in clinical trials (slight urticaria, diarrhoea).
NEŽELENI UČINKI V kliničnih preskušanjih so zasledili posamezne primere neželenih učinkov, ki so značilni za nesteroidna protivnetna zdravila (blaga urtikarija, driska).
Disodium hydrogen-phosphate dodecahydrate Sodium benzoate
natrijev hidrogenfosfat dodekahidrat natrijev benzoat aroma medu prečiščena voda
In case of inadequate relief of pain when used in the treatment of equine colic, careful re-evaluation of the diagnosis should be made as this could indicate the need for surgical intervention.
Pri nezadostnem olajšanju s koliko povezane bolečine pri konjih moramo diagnozo ponovno skrbno preveriti,
Horses: meat and offal: 5 days.
Konji: meso in organi: 5 dni
Single intravenous or subcutaneous injection at a dosage of 0.2 mg meloxicam/kg body weight (i.e. 0.4 ml/10 kg body weight) before surgery, for example at the time of induction of anaesthesia.
Enkratna intravenska ali podkožna injekcija po 0,2 mg meloksikama na kilogram telesne mase (to je 0,4 ml/10 kg telesne mase) pred operacijo, na primer ob indukciji anestezije.
Inflacam 1.5 mg/ml oral suspension for dogs or Inflacam 1 mg and 2.5 mg chewable tablets for dogs may be used for continuation of treatment at a dosage of 0.1 mg meloxicam/kg body weight, 24 hours after administration of the injection.
Zdravljenje lahko nadaljujemo s peroralno suspenzijo Inflacam 1,5 mg/ml za pse ali z žvečljivimi tabletami Inflacam 1 mg in 2,5 mg za pse, ki jih damo v odmerku po 0,1 mg meloksikama na kilogram telesne mase 24 ur po injekciji.
In case of accidental self-injection, seek medical advice immediately and show the package leaflet or the label to the physician.
V primeru nenamernega samoinjiciranja se takoj posvetujte z zdravnikom in mu pokažite navodila za uporabo ali ovojnino.
These side effects occur generally within the first treatment week and are in most cases transient and disappear following termination of the treatment, but in very rare cases may be serious or fatal.
Pri se našteti neželeni učinki pretežno pojavijo v prvem tednu zdravljenja, so večinoma prehodni in po končanem zdravljenju minejo, vendar so lahko v zelo redkih primerih tudi resni ali smrtno nevarni.
Single subcutaneous injection at a dosage of 0.3 mg meloxicam/kg body weight (i.e. 0.06 ml/kg body weight) before surgery, for example at the time of induction of anaesthesia.
Enkratna podkožna injekcija po 0,3 mg meloksikama na kilogram telesne mase (to je 0,06 ml/kg telesne mase) pred operacijo, na primer ob indukciji anestezije.
The use of Inflacam oral suspension for dogs may be considered for an even more precise dosing.
Za še natančnejše odmerjanje presodimo o uporabi Inflacam peroralne suspenzije za pse.
The treatment-free period, however, should take into account the pharmacokinetic properties of the products used previously.
Poleg tega je treba pri določanju obdobja brez zdravil upoštevati farmakokinetične lastnosti zdravil, ki smo jih dajali predhodno.
Meloxicam also has anti-endotoxic properties because it has been shown to inhibit production of thromboxane B2 induced by intravenous E. coli endotoxin administration in calves and pigs.
Meloxilam ima tudi antiendotoksične lastnosti, saj so dokazali, da zavira nastajanje tromboksana B2 ki je izzvano z intravenskim vnosom endotoksina E. Coli pri teletih in prašičih.
In dogs, meloxicam is eliminated with a half-life of 24 hours.
Pri psih je razpolovna doba izločanja meloksikama 24 ur.
NAME AND ADDRESS OF THE MARKETING AUTHORISATION HOLDER AND OF THE MANUFACTURING AUTHORISATION HOLDER RESPONSIBLE FOR BATCH RELEASE, IF DIFFERENT
IME IN NASLOV IMETNIKA DOVOLJENJA ZA PROMET Z ZDRAVILOM TER IMETNIKA DOVOLJENJA ZA IZDELAVO ZDRAVILA, ODGOVORNEGA ZA
Inflacam 0.5 mg/ml oral suspension for cats
Inflacam 0,5 mg/ml peroralna suspenzija za mačke
Inflacam 20 mg/ml solution for injection for cattle, pigs and horses
Inflacam 20 mg/ml raztopina za injiciranje za govedo, prašiče in konje
White high density polyethylene bottle containing 10 ml or 15 ml with a tamper proof child resistant closure.
6.5 Vrsta ovojnine in vsebina Bela polietilenska plastenka z visoko gostoto, ki vsebuje 10 ml ali 15 ml z za otroke varnim zapiralom.
Cats: single administration of 0.3 mg meloxicam/kg body weight (i.e. 0.06 ml/kg).
Mačke: Enkratni odmerek po 0,3 mg meloksikama na kilogram telesne mase (to je 0,06 ml/kg).
Route and method of administration
Pot in način uporabe zdravila
Chanelle Pharmaceuticals Manufacturing Ltd., Loughrea, Co. Galway, Ireland.
Chanelle Pharmaceuticals Manufacturing Ltd. Loughrea, Co. Galway, IRSKA.
After a single subcutaneous dose of 0.5 mg meloxicam/kg, Cmax values of 2.1 μg/ml were reached after 7.7 hours in young cattle.
Po enkratnem podkožnem odmerku meloksikama po 0,5 mg/kg je znašala Cmax pri mladem govedu 2,1 µg/ml po 7,7 ure.
The suspension can be given using the measuring syringe provided in the package.
Suspenzijo lahko dajemo s priloženo merilno brizgo.
Horses Do not use in pregnant or lactating mares.
Konji Ne uporabite pri brejih kobilah ali kobilah v obdobju laktacije.
These side effects occur generally within the first treatment week and are in most cases transient and disappear following termination of the treatment but in very rare cases may be serious or fatal.
Pri se našteti neželeni škodljivi učinki pretežno pojavijo v prvem tednu zdravljenja, so večinoma prehodni in po končanem zdravljenju minejo, vendar so lahko v zelo redkih primerih tudi resni ali smrtno nevarni.
Single intramuscular injection at a dosage of 0.4 mg meloxicam/kg body weight (i.e. 0.4 ml/5 kg body weight) before surgery.
Enkratna intramuskularna injekcija odmerka po 0,4 mg meloksikama na kilogram telesne mase (to je 0,4 ml/5 kg telesne mase) pred operacijo.
Meloxicam 5 mg, Ethanol (96%) 159.8 mg. Clear, yellow solution.
Meloksikam 5 mg Etanol (96%) 159.8 mg Prozorna rumena raztopina.
Each chewable tablet contains:
KAKOVOSTNA IN KOLIČINSKA SESTAVA Vsaka vrečica vsebuje:
Special precautions for use in animals:
POSEBNO(A) OPOZORILO(A) Posebni previdnostni ukrepi za uporabo pri živalih:
Oral use
NAVODILO ZA UPORABO
Approximately 50 % of the administered dose is eliminated via urine and the remainder via faeces.
Približno 50 % vnesenega odmerka se izloči s sečem, preostanek pa z blatom.
The treatment-free period, however, should take into account the pharmacological properties of the products used previously.
Poleg tega je treba pri določanju obdobja brez zdravil upoštevati farmakološke lastnosti zdravil, ki smo jih dajali predhodno.
Package sizes: 20 tablets 100 tablets
VELIKOST PAKIRANJA 20 tablet
Label for 10 ml and 20 ml vials
OVOJNINAH Nalepka za 10 ml ali 20 ml vialo
Saccharin sodium Carmellose sodium Silica, colloidal anhydrous Citric acid monohydrate Sorbitol, liquid (non-crystallising) Disodium phosphate dodecahydrate Sodium benzoate
6.1 Seznam pomožnih snovi natrijev saharinat natrijeva karboksimetilceluloza silicijev dioksid, koloidni, brezvodni citronska kislina monohidrat raztopina sorbitola natrijev hidrogenfosfat dodekahidrat natrijev benzoat aroma medu.
Inflacam 330 mg granules for horses
NAVODILO ZA UPORABO Inflacam 330 mg, zrnca za konje
Pregnancy and lactation: Do not use in pregnant or lactating mares.
Brejosti in laktacije Ne uporabite pri kobilah v obdobju brejosti in laktacije.
Label for 100 ml and 250 ml bottles
Nalepka za 100 ml in 250 ml plastenki
Dogs: IV or SC. Cats: SC.
Mačke: s.c.
Do not use in pregnant or lactating animals.
Ne uporabite pri brejih živalih in živalih v obdobju laktacije.
Single intramuscular injection.
FARMACEVTSKA OBLIKA Raztopina za injiciranje.
Label for 50 ml, 100 ml and 250 ml
Nalepka za 50 ml, 100 ml in 250 ml viale
Carton box containing one colourless glass injection vial of 10 ml, 20 ml or 100ml, closed with a bromobutyl rubber stopper and sealed with an aluminium cap.
Kartonska škatla z eno brezbarvno stekleno injekcijsko vialo po 10 ml, 20 ml ali 100 ml. Viale so zaprte z gumijastimi zamaški in aluminijastimi zaporkami.
Read package leaflet before use.
Pred uporabo preberite navodilo za uporabo.
To obtain the best possible pain relieving post-surgery Inflacam should be administered 30 minutes before surgical intervention.
Najboljše možno lajšanje bolečine po operaciji boste dosegli, če boste zdravilo Inflacam uporabili 30
Pharmacotherapeutic group: Anti-inflammatory and anti-rheumatic products, non-steroids; oxicams.
Farmakoterapevtska skupina: Nesteroidna protivnetna in protirevmatična zdravila; oksikami.
In very rare cases anaphylactoid reactions may occur and should be treated symptomatically.
Zelo redko se lahko pojavijo anafilaktoidne reakcije, ki jih je treba zdraviti simptomatsko.
Inflacam 5 mg/ml solution for injection for cattle and pigs
Inflacam 5 mg/ml raztopina za injiciranje za govedo in prašiče
Alleviation of pain and inflammation in acute and chronic musculo-skeletal disorders in cats.
Lajšanje bolečine in umirjanje vnetja pri akutnih in kroničnih mišično-skeletnih obolenjih pri mačkah.
Dogs: single administration of 0.2 mg meloxicam /kg body weight (i.e. 0.4 ml/10 kg).
Psi: Enkratni odmerek po 0,2 mg meloksikama na kilogram telesne mase (to je 0,4 ml/10 kg).
Overdose (symptoms, emergency procedures, antidotes): In the case of overdose, symptomatic treatment should be initiated.
Preveliko odmerjanje (simptomi, nujni ukrepi, protistrupi) V primeru prevelikega odmerka je potrebno uvesti simptomatsko zdravljenje.
Label for 15 ml and 42 ml bottle
OVOJNINAH Nalepka za 15 ml ali 42 ml plastenki
Carton box containing 1 colourless glass injection vial of 20 ml, 50 ml or 100 ml, closed with a bromobutyl rubber stopper and sealed with an aluminium cap.
Kartonska škatla z 1 brezbarvno stekleno injekcijsko vialo po 20 ml, 50 ml ali 100 ml. Viale so zaprte z bromobutilnimi gumijastimi zamaški in aluminijastimi zaporkami.
Inflacam 15 mg/ml oral suspension for horses
NAVODILO ZA UPORABO Inflacam 15 mg/ml, peroralna suspenzija za konje
Single intravenous injection at a dosage of 0.6 mg meloxicam/kg body weight (i.e. 3.0 ml/100 kg body weight).
Enkratna intravenska injekcija odmerka po 0,6 mg meloksikama na kilogram telesne mase (to je 3,0 ml/100 kg telesne mase).
Do not use in animals suffering from impaired hepatic, cardiac or renal function and haemorrhagic disorders, or where there is evidence of ulcerogenic gastrointestinal lesions.
Ne uporabite pri živalih z motnjami jetrne, srčne ali ledvične funkcije in s hemoragičnimi motnjami ter pri dokazanih ulkusnih poškodbah v prebavilih.
Alleviation of mild to moderate post-operative pain and inflammation following surgical procedures in cats, e.g. orthopaedic and soft tissue surgery.
Lajšanje blage do zmerne postoperativne bolečine in umirjanje vnetja po kirurških postopkih pri mačkah,
Sodium dihydrogen phosphate monohydrate Simethicone emulsion Honey flavour
Seznam pomožnih snovi natrijev benzoat glicerol citronska kislina monohidrat ksantanski gumi natrijev dihidrogenfosfat monohidrat simetikon emulzija silicijev dioksid, koloidni, brezvodni aroma medu prečiščena voda
Other NSAIDs, diuretics, anticoagulants, aminoglycoside antibiotics and substances with high protein binding may compete for binding and thus lead to toxic effects.
Medsebojno delovanje z drugimi zdravili in druge oblike interakcij Druga nesteroidna protivnetna zdravila, diuretiki, antikoagulanti, aminoglikozidni antibiotiki in snovi z visoko vezavo na beljakovine se lahko kompetitivno vežejo, kar lahko privede do toksičnih učinkov.
In vitro and in vivo studies demonstrated that meloxicam inhibits cyclooxygenase-2 (COX-2) to a greater extent than cyclooxygenase-l (COX-I).
Raziskave in vitro ter in vivo so pokazale, da meloksikam močneje zavira ciklooksigenazo 2
Smooth light yellow suspension
FARMACEVTSKA OBLIKA Peroralna suspenzija Rumeno obarvana suspenzija
Do not use after the expiry date (EXP) stated on the carton and vial.
Zdravila ne smete uporabljati po datumu izteka roka uporabnosti (EXP), navedenega na zunanji ovojnini in vsebniku.
Granules in sachet.
Zrnca v vrečici.
Do not administer concurrently with glucocorticosteroids, other non-steroidal anti-inflammatory drugs or with anticoagulant agents.
Zdravila ne uporabljajte hkrati z glukokortikosteroidi, drugimi nesteroidnimi protivnetnimi zdravili ali z antikoagulanti.
Meloxicam is eliminated with a half-life of 24 hours.
Razpolovna doba izločanja meloksikama je 24 ur.
Active substance Meloxicam 1 mg Meloxicam 2.5 mg
Zdravilna učinkovina meloksikam 1 mg meloksikam 2,5 mg
Initial treatment is a single oral dose of 0.2 mg meloxicam/kg body weight (0.4 ml/kg) on the first day.
Začetni odmerek prvi dan zdravljenja je 0,2 mg meloksikama/kg telesne mase (0,04 ml /kg).
Do not use this veterinary medicinal product after the expiry date which is stated on the carton and the sachet after EXP.
Tega zdravila ne smete uporabljati po datumu izteka roka uporabnosti, navedenega na ovojnini in plastenki po {EXP}.
Single subcutaneous injection at a dosage of 0.2 mg meloxicam/kg body weight (i.e. 0.4 ml/10 kg body weight).
Enkratna podkožna injekcija po 0,2 mg meloksikama na kilogram telesne mase (to je 0,4 ml/10 kg telesne mase).
Other NSAIDs, diuretics, anti-coagulants, aminoglycoside antibiotics and substances with high protein binding may compete for binding and thus lead to toxic effects.
Medsebojno delovanje z drugimi zdravili in druge oblike interakcij Druga nesteroidna protivnetna zdravila, diuretiki, antikoagulansi, aminoglikozidni antibiotiki in snovi z veliko vezavo na beljakovine se lahko kompetitivno vežejo, kar lahko povzroči toksične učinke.